pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

4,972 catalysts · 4,970 phase readout · 2,318 8k filing · 283 earnings · 277 pdufa · 115 phase 2 completion · 53 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 0 catalysts2026-10-22: 1 catalyst2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: grant×type: approval×type: phase readout×clear all
type
  • phase readout4,970
  • 8k filing2,318
  • earnings283
  • pdufa277
  • phase 2 completion115
  • phase 1 completion53
phase 1 2 completion
28
  • phase 1 initiation26
  • phase 0 trial completion22
  • phase 1 2 initiation9
  • therapy area

    no tagged catalysts yet

    Date TBD

    50
    ›RECRUITINGphase readoutNCT05813678: A Long-term, Post-marketing Safety Study of Palynziq in Patients With PKU (PALace)

    Sponsor: BioMarin Pharmaceutical. Phase: . Conditions: Phenylketonuria (PKU)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT00720785: Natural Killer Cells and Bortezomib to Treat Cancer

    Sponsor: National Heart, Lung, and Blood Institute (NHLBI). Phase: PHASE1. Conditions: Chronic Myeloid Leukemia (CML), Pancreatic Ca, Colon/Rectal Ca, Multiple Myeloma, Carcinoma, Non-Small -Cell Lung

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04397185: Breast Cancer Locator Guided vs. Wire Localized Partial Mastectomy for Breast Cancer

    Sponsor: CairnSurgical, Inc.. Phase: NA. Conditions: Breast Cancer Female

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06834685: Evaluating Laser Photobiomodulation for the Treatment of Neuropathic Pain in Chemotherapy-induced Peripheral Neuropathy in Cancer Patients

    Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle. Phase: NA. Conditions: Cancer Survivors, Peripheral Neuropathic Pain

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07416643: The Role of Incorporating Acacia Gum in Foods on Glucose Homeostasis in Healthy Humans

    Sponsor: King Abdulaziz University. Phase: NA. Conditions: Health Adult Subjects

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04684615: Mental Health Impact of the COVID-19 Pandemic on Amish and Mennonite Participants in AMBiGen

    Sponsor: National Institute of Mental Health (NIMH). Phase: . Conditions: Depression, Anxiety, Bipolar Disorder

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07263698: Investigation of Clinical Efficacy of a New Mouthwash on Reducing Dental Plaque and Helping Prevent Gum Problems as Compared to a Control Mouthwash

    Sponsor: Colgate Palmolive. Phase: PHASE3. Conditions: Gingivitis, Plaque, Dental

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06800898: Orexin Gene in Anorexia Nervosa

    Sponsor: Istituto Auxologico Italiano. Phase: . Conditions: Anorexia Nervosa

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07634263: Why Patients Decline or Are Being Deemed Ineligible to Receive Home-based Treatment: a Mixed Methods Study

    Sponsor: Odense University Hospital. Phase: . Conditions: Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma, Multiple Myeloma Progression, Multiple Myeloma Refractory

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06700187: Frequency of Interrupting Sitting and Cognitive Function

    Sponsor: Maastricht University Medical Center. Phase: NA. Conditions: Sedentary Behaviors, Breaking Prolonged Sitting With Physical Activity

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07386587: Methotrexate Alone vs Methotrexate + Etanercept for Minimal/Low Disease Activity in Juvenile Idiopathic Arthritis

    Sponsor: University of Child Health Sciences and Children's Hospital, Lahore. Phase: PHASE3. Conditions: Juvenile Idiopathic Arthritis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07315087: CAR T-cell Therapy Targeting CD19 and BCMA(QT-019C) in Patients With Relapse/Refractory Autoimmune Diseases

    Sponsor: Institute of Hematology & Blood Diseases Hospital, China. Phase: PHASE1. Conditions: SLE - Systemic Lupus Erythematosus, SSc-Systemic Sclerosis, IIM- Idiopathic Inflammatory Myopathies, ANCA Associated Vasculitis (AAV), Connective Tissue Disease-Associated Thrombocytopenia, SLE-ITP

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07600463: UVC in Prevention of Surgical Wound Infection

    Sponsor: Ville Leinonen. Phase: NA. Conditions: Hydrocephalus

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT02777593: Evaluation of the GORE® TBE Device in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta, Zone 2

    Sponsor: W.L.Gore & Associates. Phase: NA. Conditions: Aortic Aneurysm, Thoracic, Aorta; Lesion

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05583721: Relationship Between Abnormal Myocardial Perfusion and Diastolic Dysfunction in Sickle Cell Disease Using PET

    Sponsor: St. Jude Children's Research Hospital. Phase: PHASE2. Conditions: Sickle Cell Disease

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07646314: Comparative Effects of Post-Isometric Relaxation and Reciprocal Inhibition Techniques inPiriformis Syndrome

    Sponsor: Riphah International University. Phase: NA. Conditions: Piriformis Syndrome

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06308614: Estetrol for the Treatment of Female Sexual Arousal Disorder in Postmenopausal Women

    Sponsor: Estetra. Phase: PHASE2. Conditions: Sexual Dysfunction, Physiological

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05145816: Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis

    Sponsor: University of Texas Southwestern Medical Center. Phase: PHASE1. Conditions: AL Amyloidosis, Amyloidosis

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT04996316: MammoScreen Breast Cancer Risk Assessment and Decision Aid for Breast Cancer Screening and Referrals

    Sponsor: OHSU Knight Cancer Institute. Phase: . Conditions: Breast Carcinoma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05709106: A Prospective Real World Study of Rimegepant in the Treatment of Migraine

    Sponsor: Ruijin-Hainan Hospital Shanghai Jiao Tong University School Of Medicine. Phase: . Conditions: Migraine

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05085704: Brain Metabolism Observed at 3 Tesla or 7 Tesla in Health and Metabolic Disease

    Sponsor: Weill Medical College of Cornell University. Phase: . Conditions: Glut1 Deficiency Syndrome 1, Glucose Metabolism Disorders, Epilepsy, Glut1 Deficiency Syndrome 1, Autosomal Recessive, Glucose Transporter Type 1 Deficiency Syndrome, Glucose Transporter Protein Type 1 Deficiency Syndrome, Glucose Transport Defect

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07492433: Risk Factors, Incidence, and Clinical Impact of Intraluminal Thrombosis Following FET and TEVAR

    Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico. Phase: . Conditions: Intraluminal Thrombosis, Tevar, FET

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT01417533: A Natural History Study of Patients With GNE Myopathy and GNE-Related Diseases

    Sponsor: National Human Genome Research Institute (NHGRI). Phase: . Conditions: GNE Myopathy, GNE Related Diseases

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07401147: Transcutaneous Electrical Nerve Stimulation (TENS) for Pain Management During Labor.

    Sponsor: Ricardo A Gutierrez Ramirez, MD, MSc, FACOG. Phase: NA. Conditions: Labor Pain

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT03373084: Imaging Location of Hamstring Muscle Lesions in Sport and Relationships With Injury Mechanism.

    Sponsor: Centre Hospitalier Universitaire de Saint Etienne. Phase: . Conditions: Sport Injury, Hamstring Muscle Lesions

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06776952: A Randomized, Double-blind, Multicenter Phase III Study of XNW5004 Tablets in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma

    Sponsor: Evopoint Biosciences Inc.. Phase: PHASE3. Conditions: Relapsed/Refractory Peripheral T Cell Lymphoma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05085249: Improving Goal Directed Medical Therapy for Device Clinic Patients With Reduced EF at UOHI: a QI Initiative (VIGILANT)

    Sponsor: Ottawa Heart Institute Research Corporation. Phase: . Conditions: Heart Failure

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06019949: Spinal Cord Stimulation for Respiratory Rehabilitation in Patients With Chronic Spinal Cord Injury

    Sponsor: University of Louisville. Phase: NA. Conditions: Spinal Cord Injuries, Respiration Disorders

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05602038: Comparative Study on the Effect of Quadratus Lumborum Block Versus Intrathecal Morphine on the Incidence of Chronic Pain Post Caesarean Section

    Sponsor: Menoufia University. Phase: NA. Conditions: Chronic Post Cesarean Pain

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07545538: Carbohydrate Loading in Lowering Perioperative Insulin Resistance in Pediatric Surgery

    Sponsor: Gadjah Mada University. Phase: NA. Conditions: Insulin Resistance

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06299748: A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy and/or Breastfeeding.

    Sponsor: argenx. Phase: . Conditions: Myasthenia Gravis, CIDP - Chronic Inflammatory Demyelinating Polyneuropathy

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03625648: Pentoxifylline in Diabetic Kidney Disease

    Sponsor: VA Office of Research and Development. Phase: PHASE4. Conditions: Diabetic Kidney Disease

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07495748: Comparative Evaluation of Topical Metformin and Topical Tranexamic Acid in Melasma

    Sponsor: Foundation University Islamabad. Phase: NA. Conditions: Melasma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07179848: Safety and Feasibility of Temporal Interference Brain Stimulation for Treatment in Psychiatric Disorders

    Sponsor: Taipei Veterans General Hospital, Taiwan. Phase: PHASE1. Conditions: Health Adults, Temporal Interference Stimulation, Safety and Effectiveness, Crossover Study

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07560878: Synaptic Mechanisms of Continuous Theta Burst Stimulation in Depression

    Sponsor: Mclean Hospital. Phase: EARLY_PHASE1. Conditions: Major Depression

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07397078: Clinical Accuracy Validation of the Moni-Patch Temperature Monitoring Patch System

    Sponsor: Murata Vios, Inc.. Phase: NA. Conditions: Body Temperature, Febrile

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04617678: A Comprehensive Approach to Head and Neck Cancer Prehabilitation

    Sponsor: Sanford Health. Phase: NA. Conditions: Cancer of Head and Neck

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07525778: Evaluating WhatsOK Helpline for Youth With Concerns About Sexual Thoughts and Behaviors

    Sponsor: Center for Violence Prevention Research Inc. Phase: NA. Conditions: Mental Health, Social Support, Perceived Self-efficacy, Sexual Behavior

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07575178: Obstacle Course Versus Neuromotor Task Training in Children With DCD

    Sponsor: Riphah International University. Phase: NA. Conditions: Developmental Coordination Disorder (DCD)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03910478: Dried Blood Spot Testing of CMV Detection in HCT Recipients

    Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: NA. Conditions: Cytomegalovirus Infection

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06892743: Analgesic Efficacy of Ultrasound-guided External Oblique Intercostal Plane Block Versus Posterior Transversus Abdominis Plane Block in Patients Undergoing Open Nephrectomy

    Sponsor: Cairo University. Phase: NA. Conditions: Postoperative Pain

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07224243: Impact of Intraoperative Oxygenation Practices on Patient Outcomes

    Sponsor: Frederic T Billings IV. Phase: NA. Conditions: Surgeries Undergoing General Anesthesia

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT03295279: WTC Chest CT Imaging Archive

    Sponsor: Icahn School of Medicine at Mount Sinai. Phase: . Conditions: Chronic Airway Disease, Interstitial Lung Disease, Lung Cancer

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06631079: Personalised Neoantigen-targeting Cancer Vaccine NECVAX-NEO1 in Anti-PD-1/PD-L1 Therapy in Patients With Solid Tumors

    Sponsor: NEC Bio B.V. Phase: PHASE1. Conditions: Solid Tumor

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07483879: Biomarkers of Acute Organ Injury in Pediatric Newly Diagnosed Type 1 Diabetes

    Sponsor: Aristotle University Of Thessaloniki. Phase: . Conditions: Type 1 Diabetes Mellitus, Diabetic Ketoacidosis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06692179: An Open-Label, Pilot Clinical Trial To Test The Safety And Feasibility Of A Suspension of Freeze-dried Microbiota In Patients Undergoing Colon Resection

    Sponsor: University of Minnesota. Phase: PHASE1. Conditions: Recurrent Clostridioides Difficile Infection, Colonic Surgery

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT05576896: Hydroxychloroquine in Combination With Encorafenib and Cetuximab or Panitumumab in the Treatment of Metastatic BRAF-mutated Colorectal Cancer Refractory

    Sponsor: Northwestern University. Phase: PHASE2. Conditions: Stage IV Colorectal Cancer Positive for BRAF V600E Mutation, Colorectal Cancer, Colorectal Cancer Stage IV

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07334496: A Study to Evaluate the Biosimilarity of GLR1044 Injection and Dupilumab Injection (Dupixent®) in Healthy Adult Male Subjects

    Sponsor: Gan & Lee Pharmaceuticals.. Phase: PHASE1. Conditions: Biosimilarity

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07520162: A Study to Investigate NPS and Symptoms in Chinese Adult Participants With CRSwNP Initiating Treatment With Tezepelumab

    Sponsor: AstraZeneca. Phase: PHASE3. Conditions: Chronic Rhinosinusitis With Nasal Polyps

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06743646: Efficacy and Safety of ZVS101e in Patients With Bietti 's Crystalline Dystrophy

    Sponsor: Chigenovo Co., Ltd. Phase: PHASE3. Conditions: Bietti Crystalline Corneoretinal Dystrophy, Bietti Crystalline Dystrophy

    full page →ctgov ↗
    ← prev
    page 92 of 100
    next →